Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
5 hedge funds and large institutions have $68.3K invested in Nymox Pharmaceutical Corp in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 31 closing their positions.
76% less capital invested
Capital invested by funds: $287K → $68.3K (-$219K)
86% less funds holding
Funds holding: 36 → 5 (-31)
97% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFG
Steward Financial Group
Colleyville,
Texas
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Corrigan Financial
Middletown,
Rhode Island
|
-$57.4K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$38.2K |
| 3 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$22.6K |
| 4 |
Morgan Stanley
New York
|
-$18.8K |
| 5 |
BFG
Bleakley Financial Group
Fairfield,
New Jersey
|
-$15.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KAS
26
Kestra Advisory Services
Austin,
Texas
| – | -$2.19K | -11,532 | Closed |
|
|
LNC
27
Lincoln National Corp
Radnor,
Pennsylvania
| – | -$2.13K | -11,215 | Closed |
|
28
JP Morgan Chase
New York
| – | -$1.94K | -10,219 | Closed |
|
|
GVAG
29
Great Valley Advisor Group
Wilmington,
Delaware
| – | -$1.9K | -10,000 | Closed |
|
30
Group One Trading
Chicago,
Illinois
| – | -$1.01K | -5,307 | Closed |
|
31
Wells Fargo
San Francisco,
California
| – | -$627 | -3,296 | Closed |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| – | -$381 | -2,005 | Closed |
|
33
BNP Paribas Financial Markets
Paris,
France
| – | -$163 | -859 | Closed |
|
34
Bank of America
Charlotte,
North Carolina
| – | -$134 | -708 | Closed |
|
|
SFG
35
Steward Financial Group
Colleyville,
Texas
| – | +$24 | +100 | New |
|
NYMX Hedge Fund Activity: Q3 2023 in Review
5 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2023, worth a combined $68.3K — down 76% from $287K a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of NYMX and 1 opened new positions — a net loss of 30 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Steward Financial Group, opening a new position worth an estimated $24. The largest seller was Corrigan Financial, exiting entirely with an estimated $57.4K sold.
- 5 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2023, down from 36 in Q2 2023.
- Funds reported $68.3K of Nymox Pharmaceutical Corp stock for Q3 2023, down 76% quarter-over-quarter.
- 1 fund opened new Nymox Pharmaceutical Corp positions in Q3 2023 and 31 closed out, a net change of -30 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q3 2023 was Steward Financial Group, an estimated $24 added.
- The largest Nymox Pharmaceutical Corp seller in Q3 2023 was Corrigan Financial, an estimated $57.4K sold.
Based on aggregated 13F filings for Q3 2023.